Fig. 1From: Value of montelukast as a potential treatment of post-COVID-19 persistent cough: a non-randomized controlled pilot studyExperimentally supported properties of cyst LT1 receptor antagonists potentially beneficial in COVID-19 (adapted from Barré et al. 2020)Back to article page